stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Rapid agent restores ...
Depression deconstructed – NIH study.

Using social media to better ...
NIH announces 11 awards funded across three ...

NIH to admit Texas nurse ...
NIH is taking every precaution to ensure the ...

Study casts doubt on plans to ...
Intervention of no benefit, could increase ...

Scientists sniff out ...
NIH scientists find that restocking new cells in ...

Dr. Craig J. McClain to ...
The lecture is titled "Nutrition, Gut Barrier ...

NIH invests almost $32 ...
BD2K programs are at the forefront of NIH’s ...

Increased health risks linked ...
Researchers call for coordinated care to address ...

NIH Grantee Honored With 2014 ...
Early prototype microscope built at NIH.

NIH funds research consortia ...
$29 million awarded to expand NCATS' ...

Patient Exposed To Ebola ...
The patient exposed to Ebola admitted to the NIH ...

Candidate H7N9 avian flu ...
Results of large NIH-sponsored trial published.

NIH Common Fund announces ...
NIH to fund 85 awards to support highly ...

HHS releases 13th Report on ...
The report identifies chemical, biological, and ...

NIH awards initial $46 ...
Projects lay the groundwork for visualizing the ...

NIH awards seven new vaccine ...
Scientists will use experimental and ...

Patient with exposure to ...
A patient with exposure to Ebola arrives at NIH ...

NIH to admit patient exposed ...
NIH expects to admit a patient who has been ...

NIH and FDA win top award for ...
The vaccine has a low production cost and does ...

NIH and VA address pain and ...
Research will focus on nondrug approaches.

NIH exceptional responders to ...
Study to investigate the molecular factors of ...

NIH announces network to ...
Partnership includes support from industry and ...

NIH funds next phase of ...
Scientists will integrate chips mimicking human ...

NIH awards $35 Million for ...
Three research teams receive funding over next ...